DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amoclan (Amoxicillin / Clavulanate Potassium) - Published Studies

 
 



Amoclan Related Published Studies

Well-designed clinical trials related to Amoclan (Amoxicillin / Clavulanic Acid)

Amoxicillin/clavulanic acid-warfarin drug interaction: a randomized controlled trial. [2011.02]

Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study. [2009.01]

Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg). [2007.04]

Well-designed clinical trials possibly related to Amoclan (Amoxicillin / Clavulanic Acid)

The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomised, double-blind, placebo-controlled pilot clinical study. Part 3: Le Fort and zygomatic fractures in 94 patients. [2014]

The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomised, double-blind, placebo-controlled pilot clinical study. Part 1: orbital fractures in 62 patients. [2013]

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. [2011]

Antibiotic therapy in preterm premature rupture of the membranes. [2009.09]

The efficacy and safety of cefovecin in the treatment of feline abscesses and infected wounds. [2007.12]

Clinical efficacy and safety of cefovecin in the treatment of canine pyoderma and wound infections. [2007.07]

Single dose versus 5-day course of oral prulifloxacin in antimicrobial prophylaxis for transrectal prostate biopsy. [2007.03]

Other research related to Amoclan (Amoxicillin / Clavulanic Acid)

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study. [2013]

Moxifloxacin vs amoxicillin/clavulanic acid in outpatient AECOPD: maestral results. [2011.12.01]

Treatment of aseptic dogs with hemorrhagic gastroenteritis with amoxicillin/clavulanic acid: a prospective blinded study. [2011.09]

Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid. [2011.03]

The efficacy and safety of amoxicillin-clavulanic acid 1000/125mg twice daily extended release (XR) tablet for the treatment of bacterial community-acquired pneumonia in adults. [2011.02]

Treatment of aseptic dogs with hemorrhagic gastroenteritis with amoxicillin/clavulanic acid: a prospective blinded study. [2011]

Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation. [2010.10]

Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. [2008.03]

Tissue depletion of amoxicillin and its major metabolites in pigs: influence of the administration route and the simultaneous dosage of clavulanic acid. [2008.01.23]

Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. [2007.07]

Other possibly related research studies

Antibiotic resistance in urinary tract bacteria in Ouagadougou. [2009.05.01]

Rapid adaptation of antibiotic therapy for community-acquired peritonitis using direct cultures on antibiotic agar plates: pilot study. [2009.08]

[Perioperative antibiotic prophylaxis in dermatologic surgery. Update 2009] [2009.07]

Toxin A-producing Clostridium difficile as an aetiological factor of post-traumatic wound infection. [2009.07]

Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. [2009.05.13]

Treatment of acute bacterial exacerbations of chronic bronchitis. [2009.05]

Antibiotic usage, dosage and course length in children between 0 and 4 years. [2009.07]

Transsplenic portal catheterization combined with a jugular double-lumen catheter for pharmacokinetic and presystemic metabolization studies in pigs. [2009.04]

Antimicrobial resistance in Escherichia coli strains isolated from Swiss weaned pigs and sows. [2009.03]

Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci. [2009.02]

Diagnosis of clavulanic acid allergy using basophil activation and leukotriene release by basophils. [2008]

The additional costs of antibiotics and re-consultations for antibiotic-resistant Escherichia coli urinary tract infections managed in general practice. [2009.03]

Hypersensitivity to clavulanic acid in children. [2008.09]

Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children. [2008]

Mycoplasma pneumoniae-associated mucositis with minimal skin manifestations. [2008]

Sporadic and outbreak cases of melioidosis in southern Taiwan: clinical features and antimicrobial susceptibility. [2009.02]

Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). [2009.01]

Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in children. [2008]

Septic arthritis of the knee due to Prevotella loescheii following tooth extraction. [2008.08.01]

Drug utilisation 90% (DU90%) profiles of antibiotics in five Chinese children's hospitals (2002-2006). [2008.09]

Antibiotic drug use of children in the Netherlands from 1999 till 2005. [2008.09]

Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. [2008.11]

Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. [2008.09]

Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections. [2008.09.18]

Antimicrobial susceptibility of Haemophilus influenzae strains and antibiotics usage patterns in pediatric outpatients: results from a children's hospital in China (2000-2004). [2008.05]

Acute otitis media in children: association with day care centers--antibacterial resistance, treatment, and prevention. [2008]

Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. [2008.02]

Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy. [2007.12]

[Multicenter-evaluation of optimal cell density to determine antimicrobial susceptibility for Haemophilus influenzae by the automated RAISUS system when the early-harvested bacterial cells were used] [2007.07]

Resistance of Haemophilus influenzae isolates in children under 5 years old with acute respiratory infections in China between 2000 and 2002. [2007.07]

Searching for a needle in a haystack: use of ICD-9-CM codes in drug-induced liver injury. [2007.11]

Mid-trimester amniocentesis and antibiotic prophylaxis. [2007.10]

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials. [2007.08]

Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. [2007.03]

Comparative investigation of prevalence and antimicrobial resistance of Salmonella between pasture and conventionally reared poultry. [2007.03]

[Salmonella meningitis in Ouagadougou, Burkina Faso, from 2000 to 2004] [2007.02]

Efficacy of humanlike Augmentin SR (2000/125 mg) twice daily treatment on Haemophilus influenzae experimental pneumonia in rabbits. [2007]

Extended double disc synergy testing reveals a low prevalence of extended-spectrum {beta}-lactamases in Enterobacter spp. in Vienna, Austria. [2007.05]

[Bacterial infections in liver cirrhosis] [2007.03.04]

Invasive Haemophilus influenzae infections in children in Kamikawa subprefecture, Hokkaido, Japan, 1996-2005, before the introduction of H. influenzae type b vaccination. [2007.02]

Oral beta-lactams applied to uncomplicated infections of skin and skin structures. [2007.03]

Parapharyngeal abscess in a patient receiving etanercept. [2007.02]

Prevalence of antimicrobial resistance among Salmonella on midwest and northeast USA dairy farms. [2007.05.16]

Antimicrobial prophylaxis in oral surgery and dental procedures. [2007.01.01]

Self-medication with antibiotics in rural population in Greece: a cross-sectional multicenter study. [2010.08.08]

Successful treatment of a chronic facial abscess using a prolonged release antibiotic copolymer in a golden lion tamarin (Leontopithecus rosalia). [2010.06]

Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study. [2010.07]

Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital. [2009.12]

The diagnosis and treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease and chronic bronchitis. [2010.03]

Rhodococcus equi infection in HIV-infected individuals: case reports and review of the literature. [2010.04]

2-Chloroadenosine (2-CADO) treatment modulates the pro-inflammatory immune response to prevent acute lung inflammation in BALB/c mice suffering from Klebsiella pneumoniae B5055-induced pneumonia. [2010.06]

Prospective drug safety monitoring using the UK primary-care General Practice Research Database: theoretical framework, feasibility analysis and extrapolation to future scenarios. [2010.03.01]

Antimicrobial susceptibility of moxifloxacin against gram-negative enteric rods from colombian patients with chronic periodontitis. [2010.02]

In vitro killing activity of crevicular concentrations of tinidazole plus common oral antibiotics against high-density mixed inocula of periodontal pathogens in strict anaerobic conditions. [2010.01]

Safe and feasible outpatient treatment following induction and consolidation chemotherapy for patients with acute leukaemia. [2010.04]

Chronic obstructive pulmonary disease: role of bacteria and updated guide to antibacterial selection in the older patient. [2009]

Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment. [2010.01]

Antimicrobial therapy and aerobic bacteriologic culture patterns in canine intensive care unit patients: 74 dogs (January-June 2006). [2009.10]

[Retro- and parapharyngeal infections: standardization of their management] [2009.09]

Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. [2010]

[Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms] [2009.06]

Childhood suppurative otitis media in Abakaliki: isolated microbes and in vitro antibiotic sensitivity pattern. [2011.04]

Antibiotic treatment schemes for very severe community-acquired pneumonia in children: a randomized clinical study. [2011.06]

Antibiotic resistance of canine Staphylococcus intermedius group (SIG)--practical implications. [2011]

[Interstitial pneumonia after infliximab therapy for psoriasis]. [2011.06]

Cutaneous abscess after Conus textile sting. [2011.05]

Estimation of the clinical and economic consequences of non-compliance with antimicrobial treatment of canine skin infections. [2011.05.01]

Epizootic rabbit enteropathy inoculum (TEC4): antibiograms and antibiotic fractionation. [2011.01]

Antimicrobial susceptibility of Bordetella bronchiseptica isolates from pigs with respiratory diseases on farms in China. [2011.01]

Antibiotic resistance of subgingival species in chronic periodontitis patients. [2010.08]

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. [2011.03]

Sensitivity to antibiotics of Arcanobacterium pyogenes and Escherichia coli from the uteri of cows with metritis/endometritis. [2011.02]

Feline bacterial urinary tract infections: An update on an evolving clinical problem. [2011.01]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017